ATC code M05
# ATC code M05

ATC code M05 Drugs for treatment of bone diseases is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup M05 is part of the anatomical group M Musculo-skeletal system.

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM05. National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

## M05B Drugs affecting bone structure and mineralization

### M05BA Bisphosphonates

    M05BA01 Etidronic acid
    M05BA02 Clodronic acid
    M05BA03 Pamidronic acid
    M05BA04 Alendronic acid
    M05BA05 Tiludronic acid
    M05BA06 Ibandronic acid
    M05BA07 Risedronic acid
    M05BA08 Zoledronic acid

### M05BB Bisphosphonates, combinations

    M05BB01 Etidronic acid and calcium, sequential
    M05BB02 Risedronic acid and calcium, sequential
    M05BB03 Alendronic acid and colecalciferol
    M05BB04 Risedronic acid, calcium and colecalciferol, sequential
    M05BB05 Alendronic acid, calcium and colecalciferol, sequential
    M05BB06 Alendronic acid and alfacalcidol, sequential
    M05BB07 Risedronic acid and colecalciferol
    M05BB08 Zoledronic acid, calcium and colecalciferol, sequential
    M05BB09 Ibandronic acid and colecalciferol

### M05BC Bone morphogenetic proteins

    M05BC01 Dibotermin alfa
    M05BC02 Eptotermin alfa

### M05BX Other drugs affecting bone structure and mineralization

    M05BX01 Ipriflavone
    M05BX02 Aluminium chlorohydrate
    M05BX03 Strontium ranelate
    M05BX04 Denosumab
    M05BX05 Burosumab
    M05BX06 Romosozumab
    M05BX07 Vosoritide
    M05BX08 Menatetrenone
    M05BX53 Strontium ranelate and colecalciferol
